Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product
- PMID: 2556261
- PMCID: PMC401588
- DOI: 10.1002/j.1460-2075.1989.tb08594.x
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product
Abstract
The E7 proteins encoded by the human papillomaviruses (HPVs) associated with anogenital lesions share significant amino acid sequence homology. The E7 proteins of these different HPVs were assessed for their ability to form complexes with the retinoblastoma tumor suppressor gene product (p105-RB). Similar to the E7 protein of HPV-16, the E7 proteins of HPV-18, HBV-6b and HPV-11 were found to associate with p105-RB in vitro. The E7 proteins of HPV types associated with a high risk of malignant progression (HPV-16 and HPV-18) formed complexes with p105-RB with equal affinities. The E7 proteins encoded by HPV types 6b and 11, which are associated with clinical lesions with a lower risk for progression, bound to p105-RB with lower affinities. The E7 protein of the bovine papillomavirus type 1 (BPV-1), which does not share structural similarity in the amino terminal region with the HPV E7 proteins, was unable to form a detectable complex with p105-RB. The amino acid sequences of the HPV-16 E7 protein involved in complex formation with p105-RB in vitro have been mapped. Only a portion of the sequences that are conserved between the HPV E7 proteins and AdE1A were necessary for association with p105-RB. Furthermore, the HPV-16 E7-p105-RB complex was detected in an HPV-16-transformed human keratinocyte cell line.
Similar articles
-
The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties.J Virol. 1990 Feb;64(2):723-30. doi: 10.1128/JVI.64.2.723-730.1990. J Virol. 1990. PMID: 2153238 Free PMC article.
-
Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.J Virol. 2001 Aug;75(15):6737-47. doi: 10.1128/JVI.75.15.6737-6747.2001. J Virol. 2001. PMID: 11435552 Free PMC article.
-
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.Science. 1989 Feb 17;243(4893):934-7. doi: 10.1126/science.2537532. Science. 1989. PMID: 2537532
-
Molecular mechanisms of transformation by the human papillomaviruses.Princess Takamatsu Symp. 1989;20:199-206. Princess Takamatsu Symp. 1989. PMID: 2562182 Review.
-
Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.Princess Takamatsu Symp. 1991;22:239-48. Princess Takamatsu Symp. 1991. PMID: 1668886 Review.
Cited by
-
DNA repair gene expression is increased in HPV positive head and neck squamous cell carcinomas.Virology. 2020 Sep;548:174-181. doi: 10.1016/j.virol.2020.07.004. Epub 2020 Jul 22. Virology. 2020. PMID: 32838940 Free PMC article.
-
Quantitative measurement of human papillomavirus type 16 e5 oncoprotein levels in epithelial cell lines by mass spectrometry.J Virol. 2012 Sep;86(17):9465-73. doi: 10.1128/JVI.01032-12. Epub 2012 Jun 27. J Virol. 2012. PMID: 22740411 Free PMC article.
-
Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage.BMC Cancer. 2021 Jun 10;21(1):688. doi: 10.1186/s12885-021-08397-0. BMC Cancer. 2021. PMID: 34112111 Free PMC article.
-
Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data.Cancers (Basel). 2021 Apr 26;13(9):2089. doi: 10.3390/cancers13092089. Cancers (Basel). 2021. PMID: 33925884 Free PMC article. Review.
-
Next generation sequencing and its applications in HPV-associated cancers.Oncotarget. 2017 Jan 31;8(5):8877-8889. doi: 10.18632/oncotarget.12830. Oncotarget. 2017. PMID: 27784002 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical